Daily Dose - Sep 11th, 2025
Daily Dose |
View online
September 11, 2025
Bioprocessing remains a strong growth driver for life science tools, bodes well for Repligen
Despite industry setbacks with adeno associated virus-based gene therapy programs, the issue is “largely overblown” for Repligen, contend Leerink Partners analysts.
Read More
AGC Biologics’ Seattle site passes FDA inspection, hits quality milestones
The mammalian and microbial biologic production facility reported a 100% batch success rate and zero findings in ISO certification audits this year.
Read More
Noxilizer secures $30M to expand nitrogen dioxide sterilization capacity
The Hanover, Maryland company raised funds to scale its nitrogen dioxide sterilization platform as demand grows for alternatives to ethylene oxide.
Read More